Microprolactinomasappear as ahypodenseareaonmagneticresonanceimaging.Serum prolactin evels
usuallycorrespondtotumoursize.oftenabove3000mUuin patients with macroadenomas.
Firstunetherapyisdopamineaaoniststolower prolactinevels.decreasetumor size.and restoregonada(
functionforpatientsharbourina svmptomaticprolactin-secretina microadenomasor macroadenoma.
Caberqouine isused in preferencetootherdopamineaaonists becausethas hiaher efficacyv innormalzina
prolactinlevels.as weu as ahiaherfreauencyvofpituitarytumor shrinkaqe.For svmptomatic patientswhodo
notachievenormauprolactinevelsor show sianificant reduction intumor sizeon standard dosesofa
dopamineagonist(resistamt prolactinomas),thedoseshould be increasedtomaximaLtoerabledoses before
referringthepatientforsurgeryAlthoughcabergolineisthouohttobesafe in pregnancy,tismolonger
needed once preqnancy occurs.tiscleartynot neededtotreat hypoaonadismandtisnot neededtocontrot
sizeofadenomaasmicroprolactinomas almost never spontaneousty increase in size.
Trans-sphenoidausurqeryisreserved for svmptomaticpatientswith prolactinomas whocannottoeratehiah
dosesofcaberaolineorwhoarenotresponsivetodopamineaaonisttherapv
@1MIN ENDOCRINE
